Jinxiang Li

544 total citations
18 papers, 386 citations indexed

About

Jinxiang Li is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Jinxiang Li has authored 18 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Nephrology and 3 papers in Epidemiology. Recurrent topics in Jinxiang Li's work include Acupuncture Treatment Research Studies (3 papers), Traditional Chinese Medicine Studies (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Jinxiang Li is often cited by papers focused on Acupuncture Treatment Research Studies (3 papers), Traditional Chinese Medicine Studies (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Jinxiang Li collaborates with scholars based in China, United States and Puerto Rico. Jinxiang Li's co-authors include Mellar P. Davis, Hanying Ding, Shaohua Hou, Hongjun Chen, Xixi Wang, Jing Wu, Shoufeng Zhang, Sheng Nie, Hong Jia and Ting Xin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Molecular Therapy and The Oncologist.

In The Last Decade

Jinxiang Li

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinxiang Li China 10 101 95 74 72 62 18 386
Sally Owens United States 12 125 1.2× 29 0.3× 37 0.5× 62 0.9× 37 0.6× 19 697
Xiaozhuang Zhang China 11 73 0.7× 41 0.4× 76 1.0× 8 0.1× 17 0.3× 33 382
Joana Chakraborty United States 11 98 1.0× 11 0.1× 51 0.7× 88 1.2× 45 0.7× 21 443
Meritxell Nomdedéu Spain 15 110 1.1× 50 0.5× 201 2.7× 23 0.3× 84 1.4× 43 686
Ney Boa‐Sorte Brazil 17 51 0.5× 213 2.2× 36 0.5× 83 1.2× 322 5.2× 69 741
Alejandro Mohar Betancourt United States 9 45 0.4× 60 0.6× 94 1.3× 52 0.7× 72 1.2× 41 372
Maoti Wei China 13 52 0.5× 48 0.5× 210 2.8× 27 0.4× 73 1.2× 38 456
Javad Ghaffari Iran 12 30 0.3× 23 0.2× 19 0.3× 32 0.4× 118 1.9× 89 532
Virginia Au Australia 11 35 0.3× 33 0.3× 18 0.2× 46 0.6× 60 1.0× 17 413
Yuyang Xu China 14 136 1.3× 7 0.1× 48 0.6× 38 0.5× 15 0.2× 61 484

Countries citing papers authored by Jinxiang Li

Since Specialization
Citations

This map shows the geographic impact of Jinxiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxiang Li more than expected).

Fields of papers citing papers by Jinxiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxiang Li. The network helps show where Jinxiang Li may publish in the future.

Co-authorship network of co-authors of Jinxiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxiang Li. A scholar is included among the top collaborators of Jinxiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxiang Li. Jinxiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Luo, Yuxin, Sha Fu, Wenjuan Yu, et al.. (2024). Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrology. 25(1). 63–63. 7 indexed citations
3.
Li, Jinxiang, et al.. (2022). PD-1 Inhibitor-Induced Thyrotoxicosis Associated with Coronary Artery Spasm and Ventricular Tachycardia. Cardiovascular Toxicology. 22(10-11). 892–897. 3 indexed citations
4.
Li, Jinxiang, et al.. (2022). MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease. Molecular Therapy — Nucleic Acids. 28. 488–499. 27 indexed citations
5.
Ding, Hanying, Jinxiang Li, Yang Li, et al.. (2021). MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. Molecular Therapy. 29(7). 2308–2320. 52 indexed citations
6.
Zhang, Dawei, et al.. (2021). Circ_0134944 inhibits osteogenesis through miR-127-5p/PDX1/SPHK1 pathway. Regenerative Therapy. 18. 391–400. 7 indexed citations
7.
Leal, Élcio, Yong Deng, Fabiola Villanova, et al.. (2019). Isolation of a Divergent Strain of Bovine Parainfluenza Virus Type 3 (BPIV3) Infecting Cattle in China. Viruses. 11(6). 489–489. 21 indexed citations
8.
Li, Jinxiang, et al.. (2019). Kidney-secreted erythropoietin lowers lipidemia via activating JAK2-STAT5 signaling in adipose tissue. EBioMedicine. 50. 317–328. 15 indexed citations
9.
10.
Wang, Xixi, Jing Wu, Hongjun Chen, et al.. (2018). Inhibition of cGAS-STING-TBK1 signaling pathway by DP96R of ASFV China 2018/1. Biochemical and Biophysical Research Communications. 506(3). 437–443. 101 indexed citations
11.
Zhang, Wei, Qian Wen, Yue Cao, et al.. (2018). LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p. Acta Biochimica et Biophysica Sinica. 50(12). 1190–1199. 31 indexed citations
12.
Yin, Zhenyu, Jinxiang Li, Ke Ma, et al.. (2017). Development of Palliative Care in China: A Tale of Three Cities. The Oncologist. 22(11). 1362–1367. 44 indexed citations
13.
Li, Ping, Xiao-Rong Chang, Jinxiang Li, et al.. (2017). [Effect of Electroacupuncture Stimulation of Acupoints of Heart Meridian on Brain Connectivity in 27 Healthy Volunteer Subjects].. PubMed. 42(3). 229–34. 2 indexed citations
14.
15.
Guo, Yuanqing, Chuangxin Huang, Guowei Li, et al.. (2015). Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway. Molecular Medicine Reports. 12(3). 3681–3687. 18 indexed citations
16.
Cho, Jeong Yeon, Seung Hyup Kim, Sang Youn Kim, Sung Kyoung Moon, & Jinxiang Li. (2013). Efficacy and Safety of Daily Repeated Sonographically Guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids. Journal of Ultrasound in Medicine. 32(3). 397–406. 13 indexed citations
17.
Li, Jinxiang, et al.. (2011). Palliative Medicine: Barriers and Developments in Mainland China. Current Oncology Reports. 13(4). 290–294. 37 indexed citations
18.
Li, Jinxiang. (2009). Efficacy and safety of oxycodone-acetaminophen for moderate and severe visceral pain in advanced cancer patients. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Owens Breakdown of academic impact, for papers by Xiaozhuang Zhang Breakdown of academic impact, for papers by Joana Chakraborty Breakdown of academic impact, for papers by Meritxell Nomdedéu Breakdown of academic impact, for papers by Ney Boa‐Sorte Breakdown of academic impact, for papers by Alejandro Mohar Betancourt Breakdown of academic impact, for papers by Maoti Wei Breakdown of academic impact, for papers by Javad Ghaffari Breakdown of academic impact, for papers by Virginia Au Breakdown of academic impact, for papers by Yuyang Xu
Rankless by CCL
2026